Nea Management Company, LLC Adaptimmune Therapeutics PLC Transaction History
Nea Management Company, LLC
- $1.05 Billion
- Q1 2025
A detailed history of Nea Management Company, LLC transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Nea Management Company, LLC holds 17,079,778 shares of ADAP stock, worth $4.78 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
17,079,778
Previous 17,079,778
-0.0%
Holding current value
$4.78 Million
Previous $9.22 Million
62.97%
% of portfolio
0.32%
Previous 0.66%
Shares
7 transactions
Others Institutions Holding ADAP
# of Institutions
75Shares Held
114MCall Options Held
77.5KPut Options Held
14.2K-
Eco R1 Capital, LLC San Francisco, CA27.4MShares$7.67 Million0.43% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR23.8MShares$6.65 Million0.16% of portfolio
-
Two Seas Capital LP Rye, NY20.5MShares$5.75 Million0.15% of portfolio
-
Mpm Asset Management LLC Cambridge, MA5.34MShares$1.49 Million1.54% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.89MShares$1.37 Million0.18% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $45.7M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...